Plant ID: NPO5753
Plant Latin Name: Glycosmis montana
Taxonomy Genus: Glycosmis
Taxonomy Family: Rutaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
China
HTR6; | |
TSHR; | |
TDP1; RECQL; MTOR; | |
ODC1; | |
MT-ND4; | |
TP53; | |
PMP22; GMNN; LMNA; MAPT; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Enzyme_unclassified | MTOR | Serine/threonine-protein kinase mTOR | P42345 | CHEMBL2842 |
Lyase | ODC1 | Ornithine decarboxylase | P11926 | CHEMBL1869 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Oxidoreductase | MT-ND4 | NADH-ubiquinone oxidoreductase chain 4 | P03905 | CHEMBL4499 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Small molecule receptor (family A GPCR) | HTR6 | Serotonin 6 (5-HT6) receptor | P50406 | CHEMBL3371 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | PMP22 | Peripheral myelin protein 22 | Q01453 | CHEMBL1293298 |
Unclassified | GMNN | Geminin | O75496 | CHEMBL1293278 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 8.428E-06 | 1.835E-01 | CYP2C19, CYP2D6 |
BP | GO:0009987; cellular process | GO:0000733; DNA strand renaturation | 2.020E-05 | 1.861E-01 | RECQL, TP53 |
BP | GO:0009987; cellular process | GO:1901216; positive regulation of neuron death | 2.677E-05 | 1.861E-01 | MAPT, MTOR, TP53 |
BP | GO:0008152; metabolic process | GO:2000379; positive regulation of reactive oxygen species metabolic process | 4.274E-05 | 1.861E-01 | MAPT, MTOR, TP53 |
BP | GO:0009987; cellular process | GO:0071456; cellular response to hypoxia | 6.582E-05 | 2.389E-01 | LMNA, MTOR, TP53 |
MF | GO:0005488; binding | GO:0051721; protein phosphatase 2A binding | 2.103E-04 | 3.570E-01 | MAPT, TP53 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 3.113E-04 | 3.570E-01 | CYP2C19, CYP2D6 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 5.466E-04 | 3.570E-01 | CYP2C19, CYP2D6 |
MF | GO:0060089; molecular transducer activity | GO:0004996; thyroid-stimulating hormone receptor activity | 1.553E-03 | 5.046E-01 | TSHR |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 9.078E-05 | 6.264E-03 | HTR6, CYP2D6, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05214 | Glioma | 1.212E-03 | 2.354E-02 | TP53, MTOR |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 1.287E-03 | 2.354E-02 | TP53, MTOR |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.364E-03 | 2.354E-02 | CYP2D6, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 2.256E-03 | 2.889E-02 | TP53, MTOR |
09150 Organismal Systems | 09149 Aging | hsa04211 | Longevity regulating pathway - mammal | 2.513E-03 | 2.889E-02 | TP53, MTOR |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 3.924E-03 | 3.868E-02 | TP53, MTOR |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 5.475E-03 | 4.722E-02 | LMNA, TP53 |
09120 Genetic Information Processing | 09122 Translation | hsa03013 | RNA transport | 8.152E-03 | 6.250E-02 | SMN2, SMN1 |
09160 Human Diseases | 09161 Cancers | hsa05205 | Proteoglycans in cancer | 1.120E-02 | 7.027E-02 | TP53, MTOR |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
E00-E89: Endocrine, nutritional and metabolic diseases | Obesity | E66 | HTR6; |
C00-D49: Neoplasms | Non-small cell lung cancer | C33-C34 | MTOR; |
C00-D49: Neoplasms | Non-hodgkin's lymphoma | C85 | MTOR; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CYP2D6; |
K00-K95: Diseases of the digestive system | Ulcerative colitis | K51 | MTOR; |
C00-D49: Neoplasms | Cancer | C00-C96 | MTOR; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | MTOR; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Dementia | F01-F07 | HTR6; |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | MTOR; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | HTR6; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | HTR6; |
G00-G99: Diseases of the nervous system G00-G99 | Migraine | G43 | CYP2D6; |
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | Organ rejection | D89.8, T86 | MTOR; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | MTOR; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Emesis | R11 | HTR6; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | HTR6; |
C00-D49: Neoplasms | Bladder cancer | C67 | MTOR; |
C00-D49: Neoplasms | Multiple myeloma | C90 | MTOR; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MTOR; |
C00-D49: Neoplasms | Solid tumors | NA | MTOR; |
G00-G99: Diseases of the nervous system G00-G99 | Spinal muscular atrophy | G00-G99 | SMN1;SMN2; |
A00-B99: Certain infectious and parasitic diseases | Dutch elm disease | B81-B83 | MTOR; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Schizophrenia | F20 | HTR6; |
C00-D49: Neoplasms | Sarcoma | C81-C86 | MTOR; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | HTR6; |
I00-I99: Diseases of the circulatory system | Neurological disease | I21, I22, R52, R52.1-R52.2, R60.9, G89 | HTR6; |
I00-I99: Diseases of the circulatory system | Restenosis | I51.89 | MTOR; |
C00-D49: Neoplasms | Renal cancer | C64 | MTOR; |
C00-D49: Neoplasms | Pancreatic cancer | C25 | MTOR; |
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | Transplant rejection | D89.8, T86 | MTOR; |
NA: NA | Coronary artery restenosis | NA | MTOR; |
C00-D49: Neoplasms | Advanced kidney cancer | C64 | MTOR; |